跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Nahazole - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Nahazole
Approved
STANDARD
Nahazole
Aristopharma Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b8b7d53f08670d4b
Company
Aristopharma Ltd.
Type
Standard
Approval Details
Approval Id
b8b7d53f08670d4b
Drug Approval Philippines Name
Nahazole
Product Name
Nahazole
Registration Number
DRP-5041-02
Brand Name
Nahazole
Generic Name
Omeprazole (As Sodium)
Dosage Form
Lyophilized Powder for Injection
Dosage Strength
40 mg Lyophilized
Manufacturer
Aristopharma Ltd.
Importer
Sahar International Trading, Inc.
Distributor
Nahal Pharmaceutical
Issuance Date
28 June 2023
Expiry Date
27 June 2028
Pharmacologic Category
Proton Pump Inhibitors
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b8b7d53f08670d4b
Type
Standard
Back to Philippines FDA Approvals